A Study on the Association Between Treatment Response to Atezolizumab Plus Bevacizumab Combination Therapy for Advanced Hepatocellular Carcinoma and Gut Microbiota
. Our results suggest that gut microbiota may be associated with the efficacy of Atez/Bev treatment for advanced HCC.
Authors
- Yusuke Tanaka (ORCID: https://orcid.org/0000-0001-9301-437X)
- C. Nelson Hayes (ORCID: https://orcid.org/0000-0003-1691-3544)
- Aiko Tanaka (ORCID: https://orcid.org/0000-0002-8990-1336)
- Eisuke Murakami (ORCID: https://orcid.org/0000-0003-0357-2795)
- Masataka Tsuge (ORCID: https://orcid.org/0000-0001-7591-8287)
- Daiki Miki (ORCID: https://orcid.org/0000-0002-6505-9826)
- Yusuke Johira (ORCID: https://orcid.org/0000-0002-4521-5887)
- Atsushi Ono (ORCID: https://orcid.org/0000-0002-2482-945X)
- Hatsue Fujino (ORCID: https://orcid.org/0000-0002-9691-4960)
- Ryoichi Miura
- Tomoaki Emori
- Saki Sueda
- Kou Hashimoto
- Yuri Mitamura
- Shiro Oka
- Tomokazu Kawaoka
Institutions
- Hiroshima University (JP)
- Hiroshima University Hospital (JP)
Publication Details
- Journal
- Microorganisms
- Published
- 2026-04-12
- DOI
- https://doi.org/10.3390/microorganisms14040867
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00